HomeTDACU • NASDAQ
add
Translational Development Acquisition Units
Previous close
$10.44
Year range
$10.00 - $10.72
Market cap
228.93M USD
Avg Volume
2.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 213.66K | 248.64% |
Net income | 1.66M | 2,808.94% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.15K | -78.95% |
Total assets | 179.98M | 45,606.33% |
Total liabilities | 186.36M | 19,223.87% |
Total equity | -6.38M | — |
Shares outstanding | 21.91M | — |
Price to book | -36.00 | — |
Return on assets | -0.30% | — |
Return on capital | 8.58% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.66M | 2,808.94% |
Cash from operations | -88.10K | -117.63% |
Cash from investing | — | — |
Cash from financing | 100.00K | -48.05% |
Net change in cash | 11.90K | -92.18% |
Free cash flow | -7.98K | -106.53% |
About
Founded
2022
